GenMont Biotech Incorporation (TPE:3164)
Taiwan · Delayed Price · Currency is TWD 17.40
-0.10 (-0.57%)
May 8, 2026, 1:22 PM CST
TPE:3164 Market Cap
TPE:3164 has a market cap or net worth of 1.5 billion as of May 8, 2026. Its market cap has decreased by -5.73% in one year.
Market Cap
1.50B
Enterprise Value
1.34B
Revenue
390.95M
Ranking
n/a
PE Ratio
33.41
Stock Price
17.40
Market Cap Chart
Since May 8, 2006, TPE:3164's market cap has increased from 899.18M to 1.50B, an increase of 66.44%. That is a compound annual growth rate of 2.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 1.50B | -5.18% |
| Dec 31, 2025 | 1.58B | -9.68% |
| Dec 31, 2024 | 1.75B | -18.22% |
| Dec 29, 2023 | 2.14B | 4.39% |
| Dec 30, 2022 | 2.05B | -2.67% |
| Dec 30, 2021 | 2.10B | 9.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Synbio Tech | 1.87B |
| Anti-Microbial Savior BioteQ | 1.86B |
| TaiRx | 1.81B |
| Andros Pharmaceuticals Co.,Ltd | 1.74B |
| Great Novel Therapeutics Biotech & Medicals | 1.68B |
| Advagene Biopharma | 1.51B |
| NeoCore Technology | 1.41B |
| Enimmune | 1.37B |